Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

47 results about "Xylose metabolism" patented technology

D-Xylose is a five-carbon aldose (pentose, monosaccharide) that can be catabolized or metabolized into useful products by a variety of organisms. There are at least four different pathways for the catabolism of D-xylose: An oxido-reductase pathway is present in eukaryotic microorganisms. Prokaryotes typically use an isomerase pathway, and two oxidative pathways, called Weimberg and Dahms pathways respectively, are also present in prokaryotic microorganisms.

CDT (carbohydrate deficient transferrin)-2 new use and method using CDT-2 to promote microbial cells to transport xylo-oligosaccharides and application thereof

ActiveCN104140977AFermentation achievedLow costFungiBiofuelsBiotechnologyBeta-Xylosidase
The invention discloses a method for promoting microbial cells to transport and / or hydrolyze xylo oligosaccharides and application thereof. Experiments prove that cello-oligosaccharide transport protein CDT-2 also has xylo-oligosaccharide transport capacity, beta xylosidase GH43-2 has hydrolysis effect on the xylo-oligosaccharides, according to the method, cdt-2 gene and / or gh43-2 gene are/ is introduced into a microbial strain to obtain a recombinant microbial strain, and compared with a starting strain, the recombinant microbial strain acquires or improves the capability for transporting the xylo-oligosaccharides from extracellular to intracellular and / or hydrolyzing the xylo-oligosaccharides into xylose. By discovery of the xylo-oligosaccharide transport protein CDT-2 and application of the beta xylosidase GH43-2, an idea using modified yeast to directly use the xylo-oligosaccharides derived from hemicellulose degradation for producing biological chemicals is provided, co-fermentation of glucose, xylose, cello-oligosaccharide and xylo-oligosaccharide mixed sugar can be realized by co expression of cdt-2 and gh43-2 and cdt-1 and gh43-1 in brewer's yeast containing xylose metabolic pathway to produce the biological chemicals, and the production cost is greatly saved.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products